Group One Trading
ENVB icon

Group One Trading’s Enveric Biosciences ENVB Stock Holding History

Group One Trading’s Portfolio ENVB Stock Details ENVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1
Closed -$2 – 7823
2026
Q1 		$2 Hold
1
– – ﹤0.01% 7484
2025
Q4 		$4 Buy
+1
New +$7 ﹤0.01% 7968
2025
Q3 		– Hold
0
– – – 8294
2025
Q2 		– Sell
-2
Closed -$30 – 7842
2025
Q1 		$26 Hold
2
– – ﹤0.01% 7440
2024
Q4 		$98 Hold
2
– – ﹤0.01% 7100
2024
Q3 		$129 Hold
2
– – ﹤0.01% 6469
2024
Q2 		$169 Hold
2
– – ﹤0.01% 6524
2024
Q1 		$273 Hold
2
– – ﹤0.01% 6789
2023
Q4 		$355 Hold
2
– – ﹤0.01% 7123
2023
Q3 		$631 Hold
2
– – ﹤0.01% 7299
2023
Q2 		$920 Hold
2
– – ﹤0.01% 7275
2023
Q1 		$459 Hold
2
– – ﹤0.01% 6917
2022
Q4 		$560 Sell
2
-5
-71% -$2.77K ﹤0.01% 6930
2022
Q3 		$5K Hold
7
– – ﹤0.01% 6823
2022
Q2 		$13K Buy
7
+1
+17% +$2.13K ﹤0.01% 6603
2022
Q1 		$17K Hold
6
– – ﹤0.01% 6856
2021
Q4 		$49K Buy
+6
New +$84.3K ﹤0.01% 6353

Other funds holding ENVB

SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
SG
StoneX Group New York $2.48B AUM 33.54% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Group One Trading's ENVB Position: Q2 2026 in Review

Group One Trading sold out of Enveric Biosciences (ENVB) in Q2 2026, closing a stake of 1 share — an estimated $2 sold.

Group One Trading first reported a position in ENVB in Q4 2021 and held it in 16 quarters. The position peaked at $49K in Q4 2021. 24 funds tracked by Wall St. Rank hold ENVB as of Q2 2026.

  • Group One Trading reported no remaining Enveric Biosciences position as of Q2 2026 after selling out during the quarter.
  • Group One Trading sold 1 Enveric Biosciences share in Q2 2026, an estimated $2.
  • Group One Trading first reported a position in Enveric Biosciences in Q4 2021 and held it in 16 quarters.
  • Group One Trading's Enveric Biosciences position peaked at $49K in Q4 2021.
  • 24 funds tracked by Wall St. Rank held Enveric Biosciences as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.